The Net Margin of Genetix Biotherapeutics Inc (BLUE) is
-287.23%.
Net Margin measures the percentage of net income derived from total revenue after all expenses. It signals how much actual profit a company retains from its sales.
| Date |
Value |
| 2024-12-31 |
-287.23%
|
| 2023-12-31 |
-718.42%
|
| 2022-12-31 |
-7405.00%
|
| 2021-12-31 |
-22387.43%
|
| 2020-12-31 |
-246.79%
|
| 2019-12-31 |
-1766.44%
|
| 2018-12-31 |
-1018.01%
|
| 2017-12-31 |
-947.33%
|
| 2016-12-31 |
-4277.76%
|
| 2015-12-31 |
-1184.52%
|
| Ticker |
Name |
Value |
|
RCUS
|
Arcus Biosciences, Inc.
|
-142.91%
|
|
REGN
|
Regeneron Pharmaceuticals, Inc.
|
31.41%
|
|
FPRX
|
Five Prime Therapeutics Inc
|
-639.91%
|
|
GBIO
|
Generation Bio Co
|
-661.91%
|
|
LGND
|
Ligand Pharmaceuticals Incorporated
|
46.42%
|
|
YMAB
|
Y-mAbs Therapeutics Inc
|
-33.83%
|
|
MRNA
|
Moderna, Inc.
|
-145.16%
|
|
950160.KQ
|
Kolon TissueGene Inc
|
-3733.25%
|
|
AMGN
|
Amgen Inc
|
20.98%
|
|
BCAB
|
Bioatla Inc
|
-2980.35%
|
|
FOLD
|
Amicus Therapeutics Inc
|
-4.27%
|
|
950220.KQ
|
Neoimmunetech Inc
|
-33533.01%
|
|
KURA
|
Kura Oncology, Inc.
|
-412.95%
|
|
ABBV
|
AbbVie Inc.
|
6.91%
|
|
CGEM
|
Cullinan Therapeutics, Inc.
|
-346.20%
|
|
SGMO
|
Sangamo Therapeutics Inc
|
-310.81%
|
|
NRIX
|
Nurix Therapeutics, Inc.
|
-314.90%
|
|
FMTX
|
Forma Therapeutics Holdings Inc
|
-34.59%
|
|
INO
|
Inovio Pharmaceuticals Inc
|
-130005.97%
|
|
IRWD
|
Ironwood Pharmaceuticals, Inc.
|
8.11%
|
|
MCRB
|
Seres Therapeutics, Inc.
|
721.93%
|
|
CCCC
|
C4 Therapeutics, Inc.
|
-292.08%
|
|
CYTK
|
Cytokinetics, Incorporated
|
-891.60%
|
|
MYOV
|
Myovant Sciences Ltd
|
-89.18%
|
|
RGNX
|
REGENXBIO Inc.
|
-113.75%
|
|
QURE
|
uniQure N.V.
|
-1236.00%
|
|
ZYME
|
Zymeworks Inc.
|
-76.56%
|
|
950200.KQ
|
Psomagen Inc
|
-5.04%
|
|
ALEC
|
Alector, Inc.
|
-679.16%
|
|
DRNA
|
Dicerna Pharmaceuticals Inc
|
-68.59%
|
|
GBT
|
Global Blood Therapeutics Inc
|
-155.63%
|
|
DMTK
|
DermTech Inc
|
-659.57%
|
|
GILD
|
Gilead Sciences, Inc.
|
28.90%
|
|
IMGN
|
ImmunoGen Inc
|
-204.87%
|
|
VRTX
|
Vertex Pharmaceuticals Incorporated
|
32.94%
|